Conquering Diseases

Study Of An Investigational Drug To Reduce Spleen Volume For People With Myelofibrosis

Description

Seeking men and women with with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia for a study of an investigational drug to reduce spleen volume.

Overview

Participants in this study will be randomly selected to receive either the investigational drug or the usual best available treatment. Participation will occur in multiple 28-day cycles of treatment.

What we're hoping for

We are studying whether an investigational drug is safe and effective compared to the best usual treatment in reducing spleen volume for people with Myelofibrosis

Additional Information

ClinicalTrials.gov Identifier: NCT04854096

 Principal Investigator

Shyam  Patel, MD, PhD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989